These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2140065)

  • 41. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques.
    van Horssen J; Kleinnijenhuis J; Maass CN; Rensink AA; Otte-Höller I; David G; van den Heuvel LP; Wesseling P; de Waal RM; Verbeek MM
    Neurobiol Aging; 2002; 23(4):537-45. PubMed ID: 12009503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
    Klein DJ; Oegema TR; Brown DM
    Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basement membrane and beta amyloid fibrillogenesis in Alzheimer's disease.
    Inoue S
    Int Rev Cytol; 2001; 210():121-61. PubMed ID: 11580205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
    Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T
    FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of proteoglycans and glycosaminoglycans in bovine renal AA-type amyloidosis.
    Niewold TA; Flores Landeira JM; van den Heuvel LP; Ultee A; Tooten PC; Veerkamp JH
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(5):321-8. PubMed ID: 1685039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders.
    van Horssen J; Wesseling P; van den Heuvel LP; de Waal RM; Verbeek MM
    Lancet Neurol; 2003 Aug; 2(8):482-92. PubMed ID: 12878436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis.
    Snow AD; Bramson R; Mar H; Wight TN; Kisilevsky R
    J Histochem Cytochem; 1991 Oct; 39(10):1321-30. PubMed ID: 1940305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Properties of nervous tissue proteoglycans relevant to studies on Alzheimer's disease.
    Margolis RU; Margolis RK
    Neurobiol Aging; 1989; 10(5):500-2; discussion 510-2. PubMed ID: 2530461
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of heparan sulphate proteoglycan and retinal microinfarcts in diabetes mellitus.
    Roy MS; Rick ME
    Diabetologia; 1989 Oct; 32(10):766. PubMed ID: 2531690
    [No Abstract]   [Full Text] [Related]  

  • 51. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses.
    Snow AD; Wight TN
    Neurobiol Aging; 1989; 10(5):481-97. PubMed ID: 2682326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of secreted human neuroblastoma proteoglycans to the Alzheimer's amyloid A4 peptide.
    Buée L; Ding W; Delacourte A; Fillit H
    Brain Res; 1993 Jan; 601(1-2):154-63. PubMed ID: 8431762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparan sulphate proteoglycans.
    Gallagher JT; Turnbull JE; Lyon M
    Biochem Soc Trans; 1990 Apr; 18(2):207-9. PubMed ID: 2143154
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease.
    Vinters HV; Nishimura GS; Secor DL; Pardridge WM
    Am J Pathol; 1990 Aug; 137(2):233-40. PubMed ID: 2201197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formation of a supramolecular complex is involved in the reconstitution of basement membrane components.
    Kleinman HK; McGarvey ML; Hassell JR; Martin GR
    Biochemistry; 1983 Oct; 22(21):4969-74. PubMed ID: 6227336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunoelectron microscopy of endothelial cells in rat incisor suggests that most basement membrane components are produced by young cells, whereas heparan sulfate proteoglycan is produced by both young and old cells.
    Murray IC; Leblond CP
    J Histochem Cytochem; 1988 Jul; 36(7):763-73. PubMed ID: 2968396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
    Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
    J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vascular basement membrane pathology and Alzheimer's disease.
    Zarow C; Barron E; Chui HC; Perlmutter LS
    Ann N Y Acad Sci; 1997 Sep; 826():147-60. PubMed ID: 9329687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions of basement membrane components.
    Woodley DT; Rao CN; Hassell JR; Liotta LA; Martin GR; Kleinman HK
    Biochim Biophys Acta; 1983 Dec; 761(3):278-83. PubMed ID: 6228259
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Codistribution of heparan sulfate proteoglycan, laminin, and fibronectin in the extracellular matrix of normal rat kidney cells and their coordinate absence in transformed cells.
    Hayman EG; Oldberg A; Martin GR; Ruoslahti E
    J Cell Biol; 1982 Jul; 94(1):28-35. PubMed ID: 6214562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.